These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Targeting glutamine metabolism rescues mice from late-stage cerebral malaria. Gordon EB; Hart GT; Tran TM; Waisberg M; Akkaya M; Kim AS; Hamilton SE; Pena M; Yazew T; Qi CF; Lee CF; Lo YC; Miller LH; Powell JD; Pierce SK Proc Natl Acad Sci U S A; 2015 Oct; 112(42):13075-80. PubMed ID: 26438846 [TBL] [Abstract][Full Text] [Related]
7. Hemozoin biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors. Hempelmann E Parasitol Res; 2007 Mar; 100(4):671-6. PubMed ID: 17111179 [No Abstract] [Full Text] [Related]
8. Antimalarial effect of iron chelators. Gordeuk VR; Loyevsky M Adv Exp Med Biol; 2002; 509():251-72. PubMed ID: 12572998 [No Abstract] [Full Text] [Related]
9. Emerging avenues for the management of cerebral malaria. Das N; Prabhu P J Pharm Pharmacol; 2022 Jun; 74(6):800-811. PubMed ID: 35429389 [TBL] [Abstract][Full Text] [Related]
10. Induction of Neuroinflammation and Neurotoxicity by Synthetic Hemozoin. Velagapudi R; Kosoko AM; Olajide OA Cell Mol Neurobiol; 2019 Nov; 39(8):1187-1200. PubMed ID: 31332667 [TBL] [Abstract][Full Text] [Related]
11. The apicoplast as an antimalarial drug target. Ralph SA; D'Ombrain MC; McFadden GI Drug Resist Updat; 2001 Jun; 4(3):145-51. PubMed ID: 11768328 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin receptors and β-catenin regulate brain endothelial integrity in malaria. Gallego-Delgado J; Basu-Roy U; Ty M; Alique M; Fernandez-Arias C; Movila A; Gomes P; Weinstock A; Xu W; Edagha I; Wassmer SC; Walther T; Ruiz-Ortega M; Rodriguez A J Clin Invest; 2016 Oct; 126(10):4016-4029. PubMed ID: 27643439 [TBL] [Abstract][Full Text] [Related]
14. The Antimalarial Chloroquine Suppresses LPS-Induced NLRP3 Inflammasome Activation and Confers Protection against Murine Endotoxic Shock. Chen X; Wang N; Zhu Y; Lu Y; Liu X; Zheng J Mediators Inflamm; 2017; 2017():6543237. PubMed ID: 28321151 [TBL] [Abstract][Full Text] [Related]
15. Additive Therapy of Plasmodium berghei-Induced Experimental Cerebral Malaria via Dihydroartemisinin Combined with Rapamycin and Atorvastatin. Song X; Cheng W; Zhu H; Li Y; Li J Microbiol Spectr; 2023 Mar; 11(2):e0231722. PubMed ID: 36946739 [TBL] [Abstract][Full Text] [Related]
16. Perillyl alcohol exhibits in vitro inhibitory activity against Plasmodium falciparum and protects against experimental cerebral malaria. Rodriguez AAM; Carvalho LJM; Kimura EA; Katzin AM Int J Antimicrob Agents; 2018 Mar; 51(3):370-377. PubMed ID: 28843818 [TBL] [Abstract][Full Text] [Related]
17. Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria. Wilson NO; Solomon W; Anderson L; Patrickson J; Pitts S; Bond V; Liu M; Stiles JK PLoS One; 2013; 8(4):e60898. PubMed ID: 23630573 [TBL] [Abstract][Full Text] [Related]
18. Increased synapsin I expression in cerebral malaria. Thonsranoi K; Glaharn S; Punsawad C; Chaisri U; Krudsood S; Viriyavejakul P Int J Clin Exp Pathol; 2015; 8(11):13996-4004. PubMed ID: 26823711 [TBL] [Abstract][Full Text] [Related]
19. An Update on Recent Advances for the Treatment of Cerebral Malaria. Purohit D; Kumar S; Dutt R; Bhardwaj TR Mini Rev Med Chem; 2022; 22(12):1607-1618. PubMed ID: 34819002 [TBL] [Abstract][Full Text] [Related]
20. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update. Kumar S; Guha M; Choubey V; Maity P; Bandyopadhyay U Life Sci; 2007 Feb; 80(9):813-28. PubMed ID: 17157328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]